CRDF Q1 2018 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena

CRDFCardiff Oncology, Inc.

$133M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$100,136+5.4% YoY

Gross Profit

-$266,208-265.8% margin

Operating Income

-$5M-4648.7% margin

Net Income

-$5M-4779.7% margin

EPS (Diluted)

$-6.22

QoQ Revenue Growth

-45.9%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$10M

Total Liabilities

$6M

Stockholders' Equity

$5M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$100,136	$95,038	+5.4%
Gross Profit	-$266,208	-$521,388	+48.9%
Operating Income	-$5M	-$10M	+54.0%
Net Income	-$5M	-$10M	+52.1%